Product Information
BORTEZOMIB 3.5 MG VIAL is a generic product labeled by Eugia US LLC, priced at $43.3460 per EA under NDC 55150033701. Its NADAC has been published 48 times since May 22, 2024.
Strength
3.5 mg/1
Manufacturer
Eugia US LLCNDC
55150033701
Classification
Generic
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Last Updated
3/19/2025
Active Ingredients
BORTEZOMIBApproval Type
Generic (ANDA)
FDA Application
ANDA212825On Market Since
5/2/2022
Pharmacological Classes
Price Statistics
The NADAC for BORTEZOMIB 3.5 MG VIAL has been published 48 times since May 22, 2024, and over the history we have for it it has risen 46.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $43.3460 per EA |
|---|---|
| All-time high | $43.3460 (Apr 16, 2025) |
| All-time low | $29.6580 (May 22, 2024) |
| Median price | $34.7100 |
| Average price | $36.5803 |
| Largest weekly change | +24.9% (Dec 18, 2024) |
| Weeks tracked | 48 |
| Tracking since | May 22, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the BORTEZOMIB market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of BORTEZOMIB 3.5 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for BORTEZOMIB 3.5 MG VIAL, manufactured by Eugia US LLC, is $43.3460 per EA (NDC 55150033701), effective Apr 16, 2025.
How has the price of BORTEZOMIB 3.5 MG VIAL changed over time?
Over the history we have for it, the NADAC for BORTEZOMIB 3.5 MG VIAL has risen 46.2%. It has been tracked across 48 weekly CMS publications since May 22, 2024.
What are the highest and lowest recorded NADAC prices for BORTEZOMIB 3.5 MG VIAL?
Since May 22, 2024, the NADAC for BORTEZOMIB 3.5 MG VIAL has ranged from a low of $29.6580 (May 22, 2024) to a high of $43.3460 (Apr 16, 2025), with a median of $34.7100 per EA.
Are there cheaper alternatives to BORTEZOMIB 3.5 MG VIAL?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of BORTEZOMIB 3.5 MG VIAL, so no direct lower-cost alternative is listed.
Who manufactures BORTEZOMIB 3.5 MG VIAL?
BORTEZOMIB 3.5 MG VIAL (NDC 55150033701) is labeled by Eugia US LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification